CVS Health logo

CVS - CVS Health Share Price

$58.44 -1.1  -1.9%

Last Trade - 5:45pm

Sector
Healthcare
Size
Large Cap
Market Cap £60.36bn
Enterprise Value £102.59bn
Revenue £204.25bn
Position in Universe 123rd / 6396
Bullish
Bearish
Unlock CVS Revenue
Momentum
Relative Strength (%)
1m -7.97%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -22.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
139,367 153,290 177,546 184,786 194,579 256,776 267,056 276,798 +13.0%
+13.1 +9.4 +13.5 -3.2 -38.1 +74.5 +31.1 +4.21
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, CVS Health Corp revenues increased 6% to $132.1B. Net income applicable to common stockholders increased 49% to $4.98B. Revenues reflect Health Care Benefits segment increase of 7% to $37.67B, Retail Pharmacy Segment increase of 4% to $44.41B, Comp. Store Sales (Growth - %) - Pharmay increase of 45% to 7%, Retail Sales-Retail Pharmacy increase of 5% to $34.23B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CVS
Graphical History

Revenue

CVS Revenue Unlock CVS Revenue

Net Income

CVS Net Income Unlock CVS Revenue

Normalised EPS

CVS Normalised EPS Unlock CVS Revenue

PE Ratio Range

CVS PE Ratio Range Unlock CVS Revenue

Dividend Yield Range

CVS Dividend Yield Range Unlock CVS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CVS EPS Forecasts Unlock CVS Revenue
Profile Summary

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated August 22, 1996
Public Since October 1, 1952
No. of Shareholders: 26,656
No. of Employees: 290,000
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,308,703,450
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CVS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CVS
Upcoming Events for CVS
Wednesday 4th November, 2020 Estimate
Q3 2020 CVS Health Corp Earnings Release
Wednesday 10th February, 2021 Estimate
Q4 2020 CVS Health Corp Earnings Release
Frequently Asked Questions for CVS Health
What is the CVS Health share price?

As of 5:45pm, shares in CVS Health are trading at $58.44, giving the company a market capitalisation of £60.36bn. This share price information is delayed by 15 minutes.

How has the CVS Health share price performed this year?

Shares in CVS Health are currently trading at $58.44 and the price has moved by -6.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CVS Health price has moved by -16.56% over the past year.

What are the analyst and broker recommendations for CVS Health?

Of the analysts with advisory recommendations for CVS Health, there are there are currently 6 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CVS Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will CVS Health next release its financial results?

CVS Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the CVS Health dividend yield?

The CVS Health dividend yield is 3.36% based on the trailing twelve month period.

Does CVS Health pay a dividend?

Last year, CVS Health paid a total dividend of 2, and it currently has a trailing dividend yield of 3.36%. Looking ahead, CVS Health has not announced an ex-dividend date yet.

When does CVS Health next pay dividends?

CVS Health has yet to annouce their ex-dividend date. The historic dividend yield on CVS Health shares is currently 3.36%.

How do I buy CVS Health shares?

To buy shares in CVS Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CVS Health?

Shares in CVS Health are currently trading at $58.44, giving the company a market capitalisation of £60.36bn.

Where are CVS Health shares listed? Where are CVS Health shares listed?

Here are the trading details for CVS Health:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CVS
What kind of share is CVS Health?

Based on an overall assessment of its quality, value and momentum, CVS Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CVS Health share price forecast 2020?

Shares in CVS Health are currently priced at $58.44. At that level they are trading at 33.69% discount to the analyst consensus target price of 0.00.

Analysts covering CVS Health currently have a consensus Earnings Per Share (EPS) forecast of 7.229 for the next financial year.

How can I tell whether the CVS Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CVS Health. Over the past six months, the relative strength of its shares against the market has been -27.42%. At the current price of $58.44, shares in CVS Health are trading at -8.61% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CVS Health PE Ratio?

The CVS Health PE ratio based on its reported earnings over the past 12 months is 8.88. The shares are currently trading at $58.44.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of CVS Health?

CVS Health's management team is headed by:

Larry Merlo - CEO
David Dorman - CHM
C. David Brown - IND
Jonathan Roberts - COO
Troyen Brennan - EVP
Lisa Bisaccia - CHO
Thomas Moriarty - EVP
Eva Boratto - CFO
Nancy-Ann DeParle - IND
Alecia DeCoudreaux - IND
Roger Farah - IND
Fernando Aguirre - IND
Joshua Flum - EVP
Alan Lotvin - EVP
Karen Lynch - EVP
Who are the major shareholders of CVS Health?

Here are the top five shareholders of CVS Health based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.19% (107.2m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.53% (59.3m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.36% (57.0m shares)
Vanguard Total Stock Market Index Fund Mutual Fund
Percentage owned: 2.82% (36.8m shares)
Vanguard 500 Index Fund Mutual Fund
Percentage owned: 2.05% (26.9m shares)
Similar to CVS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.